Mylan to Buy Strides Injectables Unit for $1.6 Billion – Bloomberg
By Dr. Matthew Watson
Mylan to Buy Strides Injectables Unit for $1.6 Billion Bloomberg Mylan Inc.'s $1.6 billion agreement to buy Strides Arcolab Ltd. (STR)'s injectable-medicine unit will help the U.S. company's push into copies of expensive biotechnology drugs, Chief Executive Officer Heather Bresch said. “Injectables have been high on ... |
Uncategorized
Comments Off on Mylan to Buy Strides Injectables Unit for $1.6 Billion – Bloomberg |
March 3rd, 2013
This author published 6012 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research